Literature DB >> 16500584

Matrix metalloproteinases as markers of adverse remodeling after myocardial infarction.

Bodh I Jugdutt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16500584     DOI: 10.1016/j.cardfail.2005.10.001

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


× No keyword cloud information.
  5 in total

1.  Effect of spironolactone on cardiac remodeling after acute myocardial infarction.

Authors:  Chun-Tao Wu; Zhong-Hua Wang; Zhu-Qin Li; Lan-Feng Wang
Journal:  World J Emerg Med       Date:  2013

2.  Role of healing-specific-matricellular proteins and matrix metalloproteinases in age-related enhanced early remodeling after reperfused STEMI in dogs.

Authors:  Bodh I Jugdutt; Arivazhagan Palaniyappan; Richard R E Uwiera; Halliday Idikio
Journal:  Mol Cell Biochem       Date:  2008-11-05       Impact factor: 3.396

3.  Nampt secreted from cardiomyocytes promotes development of cardiac hypertrophy and adverse ventricular remodeling.

Authors:  Vinodkumar B Pillai; Nagalingam R Sundaresan; Gene Kim; Sadhana Samant; Liliana Moreno-Vinasco; Joe G N Garcia; Mahesh P Gupta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-11-30       Impact factor: 4.733

4.  Comparison of vasopeptidase inhibitor omapatrilat and angiotensin receptor blocker candesartan on extracellular matrix, myeloperoxidase, cytokines, and ventricular remodeling during healing after reperfused myocardial infarction.

Authors:  Arivazhagan Palaniyappan; Richard R E Uwiera; Halliday Idikio; Bodh I Jugdutt
Journal:  Mol Cell Biochem       Date:  2008-09-06       Impact factor: 3.396

5.  Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced fibrogenesis in human cardiac fibroblasts.

Authors:  Meijuan Zou; Fang Wang; Rui Gao; Jingjing Wu; Yingwei Ou; Xuguan Chen; Tongshan Wang; Xin Zhou; Wei Zhu; Ping Li; Lian-Wen Qi; Ting Jiang; Weiwei Wang; Chunyu Li; Jun Chen; Qifang He; Yan Chen
Journal:  Sci Rep       Date:  2016-04-21       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.